Putting the STING into cancer immunotherapy
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
The illustrious prize supports early-career scientists and engineers as they pursue interdisciplinary work.
The method could enable a rapid test to determine whether individuals are producing antibodies that help protect against Covid-19.
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
A survey to measure who was getting vaccinated against Covid-19 in Uganda finds health workers had an important role to play.
The global health care company Sanofi is providing $25 million to advance RNA research.
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.
New fellows are working on health records, robot control, pandemic preparedness, brain injuries, and more.
At an exhibition marking two decades since a transformative gift from the Picower Foundation, current and alumni members described research at the forefront of neuroscience and beyond.
Test that measures a person’s antibodies requires a drop of blood and takes just 10 minutes to show results.
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
In annual Compton Lecture, celebrated journalist Martin Baron outlines how a growing disregard for facts undermines civil society in the U.S.